US FDA approves first drug to delay heart failure in dogs

Jan 19 (Reuters) - Pharmaceutical company Boehringer Ingelheim said on Monday the U.S. Food and Drug Administration had approved its chewable tablet, as the first drug to delay congestive heart ...
Nature

Canine Mitral Valve Disease And Heart Failure

Canine mitral valve disease, most commonly stemming from myxomatous degeneration, is the predominant acquired cardiac condition in dogs. This disease is characterised by progressive deterioration of ...
MarketWatch

FDA approves first drug to delay the onset of congestive heart failure in dogs

The MarketWatch News Department was not involved in the creation of this content. -- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimobendan) from ...
Medindia

FDA Approves First Preventive Heart Failure Drug for Dogs

Discover how the FDA's approval of Vetmedin, the first drug to delay congestive heart failure in dogs, is transforming canine ...
Morningstar

FDA approves first drug to delay the onset of congestive heart failure in dogs

Heart disease affects approximately 10 percent of dogs in their lifetime1 VETMEDIN® (pimobendan) from Boehringer Ingelheim is the only medication approved to treat preclinical mitral valve disease in ...
Yahoo

US FDA approves first drug to delay heart failure in dogs

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012.